Delivery Order SPE2DB20D1109-SPE2DB25FP61Z
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,322.94 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,780.40 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 1.25 mcg inhalation medication in 4-gram quantities. This non-set-aside, firm fixed price delivery order was competitively awarded and has an ultimate completion date of August 19, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) with a ceiling value of $4,633.86. This firm fixed price, non-set-aside delivery order is scheduled for completion by September 12, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems. The work will be performed at the company's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,860.74 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 2.5 mcg inhaler (4 grams) on September 15, 2025, with completion scheduled for September 16, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Spiriva Respimat 2.5 mcg inhaler (4 grams) with a ceiling value of $1,629.61. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract is scheduled for completion by September 15, 2025, with fulfillment from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,107.10 to AmerisourceBergen Drug Corp on August 6, 2025, for Spiriva Respimat 1.25 mcg inhaler 4gm, a respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is scheduled for completion by August 7, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The order represents a...
- The Defense Logistics Agency awarded a $1,633.24 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 5, 2025, for the supply of Spiriva Respimat 2.5 mcg inhaler (4 grams). This non-competitive, non-set-aside delivery order is scheduled for completion by May 6, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal healthcare operations, likely for military medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,088.20 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 micrograms inhaler (4 grams) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Spiriva Respimat is a prescription maintenance bronchodilator commonly used in...
- The Defense Logistics Agency awarded a $4,865.00 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gram quantities. This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing relationship with DLA. The pharmaceutical product will be delivered to the company's corporate office...
- On August 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,188.66 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation solution (4 gm). This firm fixed-price contract, with an ultimate completion date of August 19, 2025, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP61ZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,562.12 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4gm) with an ultimate completion date of August 22, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting open competition in federal procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic pharmaceuticals, and related medical commodities. The company's federal procurement portfolio demonstrates its established capability to fulfill medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/21/25 |